Symphony

New Capabilities

FDA-cleared, now with Level I trial evidence

Aroa Biosurgery published results from a randomized controlled trial showing its Symphony wound product heals diabetic foot ulcers faster than standard care. In the company's headline analysis, 55% of ulcers closed within 12 weeks with Symphony, versus 35% with standard care alone. The study appeared in the International Wound Journal.

Updated Oct 26